Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03775564
Other study ID # 2014-A01612-45
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2014
Est. completion date December 2018

Study information

Verified date March 2019
Source Hospital Center Alpes-Isère
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

REMEDRUGBY's objective is to strengthen the capacity of users to interact with others in an assertive way and to fight against stigma. It proposes to specifically target the processes of "social cognition".

"Social cognition" brings together the mental mechanisms that allow everyone to decipher the social situations, emotions and intentions of others and interact with others in the different contexts of everyday life.

People with a psychic handicap frequently have difficulties in this area, which has often important consequences for their social and professional integration.

The REMEDRUGBY program proposes to work specifically on these processes in the context of sport (+ role Play and blog) to strengthen the ability to interact with others and to deal with the stigma that can be encountered on a daily basis.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Diagnosis of schizophrenia, schizo-affective disorder (DSM-V criteria; APA, 2013).

- French mother tongue.

- psychotropic treatment unchanged during the month prior to inclusion.

- Patients who gave their informed consent to participate in the study.

- affiliated with a social security scheme or beneficiary of such a scheme

- Subject suitable for the practice of sport.

Exclusion Criteria:

- Recent dependence and abuse on cannabis or any other substance (DSM-V criteria), except tobacco.

- Neurological disorders of vascular, infectious or neurodegenerative origin.

- taking of medicinal products with a cerebral or psychic impact (e.g., corticosteroids).

- Inability to practice sport

- Pregnancy planned or in progress

- Simultaneous Participation in any other program of remediation of social cognition, training in social skills, self-esteem.

Study Design


Intervention

Other:
REMEDRUGBY PROGRAM
1st Session presentation of the programme, its objectives and a common reflection on the concepts of stigmatization/destigmatization. 2nd to 4th session devoted to a group reflection on social conventions and their meaning followed by a practice by means of role-playing. 5th to 7th session devoted to writing comments about tournaments on the blog by working on the intentions of others and the emotional impact of comments on their recipients. 8th, 9th 11th sessions devoted to media relations with group reflection on the image of themselves and their pathology that participants wish to refer to the media, followed by a practice in role-playing games Interviewer-interviewed 10th session devoted to planning and organizing the day of matches with writing a program of the day and spreading on the blog 12th General Debriefing session Including : - 3 tournaments 8 hours of Touch Rugby
TOUCH RUGBY PROGRAM
Practical training Program at Touchrugby at the rate of 12 weekly sessions of 2 hours and 3 inter-institutional tournaments per day
TAU
Treatment as usual

Locations

Country Name City State
France Ch Annecy-Genevois Annecy Aura
France Ch Le Vinatier Bron Aura
France Chs de La Savoie Chambéry Aura
France Ch Sainte-Marie Clermont-Ferrand Aura
France CHU de CLERMONT-FERRAND Clermont-Ferrand Aura
France HCAlpesIsere Saint-Égrève Aura
France Chu Saint-Etienne Saint-Étienne Aura
France Chs Le Valmont Valence Aura

Sponsors (8)

Lead Sponsor Collaborator
Hospital Center Alpes-Isère Centre Hospitalier Annecy Genevois, Centre Hospitalier Le Valmont (Valence), Centre Hospitalier Sainte Marie de Clermont Ferrand, Centre Hospitalier Spécialisé de la Savoie (Chambéry), Centre Hospitalier Universitaire de Saint Etienne, Hôpital le Vinatier, University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

References & Publications (63)

Abu-Akel A. A neurobiological mapping of theory of mind. Brain Res Brain Res Rev. 2003 Sep;43(1):29-40. Review. — View Citation

Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophr Res. 2000 Jul 7;44(1):47-56. — View Citation

Addington J, Saeedi H, Addington D. Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. Br J Psychiatry. 2006 Oct;189:373-8. — View Citation

Aleman A, Hijman R, de Haan EH, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999 Sep;156(9):1358-66. — View Citation

Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a "theory of mind"? Cognition. 1985 Oct;21(1):37-46. — View Citation

Baudouin JY, Martin F, Tiberghien G, Verlut I, Franck N. Selective attention to facial emotion and identity in schizophrenia. Neuropsychologia. 2002;40(5):503-11. — View Citation

Bellack AS, Brown SA. Psychosocial treatments for schizophrenia. Curr Psychiatry Rep. 2001 Oct;3(5):407-12. Review. — View Citation

Bengtsson-Tops A. Mastery in patients with schizophrenia living in the community: relationship to sociodemographic and clinical characteristics, needs for care and support, and social network. J Psychiatr Ment Health Nurs. 2004 Jun;11(3):298-304. — View Citation

Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P. Persecutory delusions: a review and theoretical integration. Clin Psychol Rev. 2001 Nov;21(8):1143-92. Review. — View Citation

Bertrand MC, Sutton H, Achim AM, Malla AK, Lepage M. Social cognitive impairments in first episode psychosis. Schizophr Res. 2007 Sep;95(1-3):124-33. Epub 2007 Jul 16. — View Citation

Blair RJ. Responding to the emotions of others: dissociating forms of empathy through the study of typical and psychiatric populations. Conscious Cogn. 2005 Dec;14(4):698-718. Epub 2005 Sep 12. Review. — View Citation

Blanchard JJ, Mueser KT, Bellack AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull. 1998;24(3):413-24. — View Citation

Bora E, Yucel M, Pantelis C. Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res. 2009 Apr;109(1-3):1-9. doi: 10.1016/j.schres.2008.12.020. Epub 2009 Feb 4. — View Citation

Brohan E, Elgie R, Sartorius N, Thornicroft G; GAMIAN-Europe Study Group. Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: the GAMIAN-Europe study. Schizophr Res. 2010 Sep;122(1-3):232-8. doi: 10.1016/j.schres.2010.02.1065. Epub 2010 Mar 26. — View Citation

Brüne M. "Theory of mind" in schizophrenia: a review of the literature. Schizophr Bull. 2005 Jan;31(1):21-42. Epub 2005 Feb 16. Review. — View Citation

Chang WC, Hui CL, Tang JY, Wong GH, Lam MM, Chan SK, Chen EY. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. Schizophr Res. 2011 Dec;133(1-3):22-8. doi: 10.1016/j.schres.2011.09.006. Epub 2011 Oct 2. — View Citation

Choi J, Fiszdon JM, Medalia A. Expectancy-value theory in persistence of learning effects in schizophrenia: role of task value and perceived competency. Schizophr Bull. 2010 Sep;36(5):957-65. doi: 10.1093/schbul/sbq078. Epub 2010 Jul 15. — View Citation

Combs DR, Adams SD, Penn DL, Roberts D, Tiegreen J, Stem P. Social Cognition and Interaction Training (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophr Res. 2007 Mar;91(1-3):112-6. Epub 2007 Feb 12. — View Citation

Corcoran R, Mercer G, Frith CD. Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia. Schizophr Res. 1995 Sep;17(1):5-13. — View Citation

Corcoran R, Rowse G, Moore R, Blackwood N, Kinderman P, Howard R, Cummins S, Bentall RP. A transdiagnostic investigation of 'theory of mind' and 'jumping to conclusions' in patients with persecutory delusions. Psychol Med. 2008 Nov;38(11):1577-83. Epub 2007 Nov 16. — View Citation

Couture SM, Granholm EL, Fish SC. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophr Res. 2011 Feb;125(2-3):152-60. doi: 10.1016/j.schres.2010.09.020. Epub 2010 Oct 20. — View Citation

Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review. Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63. Epub 2006 Aug 17. Review. — View Citation

Darbà J, Minoves A, Rojo E, Jimenez F, Rejas J. Efficacy of second-generation-antipsychotics in the treatment of negative symptoms of schizophrenia: a meta-analysis of randomized clinical trials. Rev Psiquiatr Salud Ment. 2011 Jul;4(3):126-43. doi: 10.1016/j.rpsm.2011.02.005. Epub 2011 Jun 14. English, Spanish. — View Citation

de Haan L, Linszen DH, Lenior ME, de Win ED, Gorsira R. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophr Bull. 2003;29(2):341-8. — View Citation

Demily C, Franck N. Cognitive remediation: a promising tool for the treatment of schizophrenia. Expert Rev Neurother. 2008 Jul;8(7):1029-36. doi: 10.1586/14737175.8.7.1029. Review. — View Citation

Deutsch F, Madle RA. Empathy: historic and current conceptualizations, measurement, and a cognitive theoretical perspective. Hum Dev. 1975;18(4):267-87. — View Citation

Dziobek I, Rogers K, Fleck S, Bahnemann M, Heekeren HR, Wolf OT, Convit A. Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). J Autism Dev Disord. 2008 Mar;38(3):464-73. Epub 2007 Nov 8. — View Citation

Edwards J, Jackson HJ, Pattison PE. Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin Psychol Rev. 2002 Jul;22(6):789-832. Review. Erratum in: Clin Psychol Rev. 2002 Nov;22(8):1267-85. — View Citation

Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2011 Jan;35(3):573-88. doi: 10.1016/j.neubiorev.2010.07.001. Epub 2010 Jul 8. Review. — View Citation

Frith CD. Schizophrenia and theory of mind. Psychol Med. 2004 Apr;34(3):385-9. — View Citation

Galderisi S, Bucci P, Mucci A, Kirkpatrick B, Pini S, Rossi A, Vita A, Maj M. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. Schizophr Res. 2013 Jun;147(1):157-162. doi: 10.1016/j.schres.2013.03.020. Epub 2013 Apr 19. — View Citation

Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS; Eufest Study Group. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. Eur Neuropsychopharmacol. 2013 Mar;23(3):196-204. doi: 10.1016/j.euroneuro.2012.04.019. Epub 2012 May 28. — View Citation

Green MF, Leitman DI. Social cognition in schizophrenia. Schizophr Bull. 2008 Jul;34(4):670-2. doi: 10.1093/schbul/sbn045. Epub 2008 May 20. — View Citation

Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005 Oct;31(4):882-7. Epub 2005 Aug 31. — View Citation

Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull. 2008 Nov;34(6):1211-20. doi: 10.1093/schbul/sbm145. Epub 2008 Jan 8. — View Citation

Hardy-Baylé MC, Sarfati Y, Passerieux C. The cognitive basis of disorganization symptomatology in schizophrenia and its clinical correlates: toward a pathogenetic approach to disorganization. Schizophr Bull. 2003;29(3):459-71. — View Citation

Harrington L, Siegert RJ, McClure J. Theory of mind in schizophrenia: a critical review. Cogn Neuropsychiatry. 2005 Aug;10(4):249-86. — View Citation

Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull. 2006 Apr;32(2):250-8. Epub 2005 Oct 12. Review. — View Citation

Hoekert M, Kahn RS, Pijnenborg M, Aleman A. Impaired recognition and expression of emotional prosody in schizophrenia: review and meta-analysis. Schizophr Res. 2007 Nov;96(1-3):135-45. Epub 2007 Sep 4. — View Citation

Jolley S, Garety P, Bebbington P, Dunn G, Freeman D, Kuipers E, Fowler D, Hemsley D. Attributional style in psychosis--the role of affect and belief type. Behav Res Ther. 2006 Nov;44(11):1597-607. Epub 2006 Jan 24. — View Citation

Jones AP, Happé FG, Gilbert F, Burnett S, Viding E. Feeling, caring, knowing: different types of empathy deficit in boys with psychopathic tendencies and autism spectrum disorder. J Child Psychol Psychiatry. 2010 Nov;51(11):1188-97. doi: 10.1111/j.1469-7610.2010.02280.x. — View Citation

Kalpakci A, Vanwoerden S, Elhai JD, Sharp C. The Independent Contributions of Emotion Dysregulation and Hypermentalization to the "Double Dissociation" of Affective and Cognitive Empathy in Female Adolescent Inpatients With BPD. J Pers Disord. 2016 Apr;30(2):242-60. doi: 10.1521/pedi_2015_29_192. Epub 2015 Apr 23. — View Citation

Kee KS, Green MF, Mintz J, Brekke JS. Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull. 2003;29(3):487-97. — View Citation

Kohler CG, Bilker W, Hagendoorn M, Gur RE, Gur RC. Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol Psychiatry. 2000 Jul 15;48(2):127-36. — View Citation

Lahera G, Benito A, Montes JM, Fernández-Liria A, Olbert CM, Penn DL. Social cognition and interaction training (SCIT) for outpatients with bipolar disorder. J Affect Disord. 2013 Mar 20;146(1):132-6. doi: 10.1016/j.jad.2012.06.032. Epub 2012 Jul 25. — View Citation

Lawrence EJ, Shaw P, Baker D, Patel M, Sierra-Siegert M, Medford N, David AS. Empathy and enduring depersonalization: the role of self-related processes. Soc Neurosci. 2007;2(3-4):292-306. doi: 10.1080/17470910701391794. — View Citation

Lin CH, Huang CL, Chang YC, Chen PW, Lin CY, Tsai GE, Lane HY. Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia. Schizophr Res. 2013 May;146(1-3):231-7. doi: 10.1016/j.schres.2013.02.009. Epub 2013 Mar 9. — View Citation

Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med. 2010 Dec;71(12):2150-61. doi: 10.1016/j.socscimed.2010.09.030. Epub 2010 Oct 12. Review. — View Citation

Lysaker PH, Beattie NL, Strasburger AM, Davis LW. Reported history of child sexual abuse in schizophrenia: associations with heightened symptom levels and poorer participation over four months in vocational rehabilitation. J Nerv Ment Dis. 2005 Dec;193(12):790-5. — View Citation

MacLeod J, Nelson G. Programs for the promotion of family wellness and the prevention of child maltreatment: a meta-analytic review. Child Abuse Negl. 2000 Sep;24(9):1127-49. — View Citation

McGuire PK, Shah GM, Murray RM. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet. 1993 Sep 18;342(8873):703-6. — View Citation

McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007 Dec;164(12):1791-802. — View Citation

Medalia A, Choi J. Cognitive remediation in schizophrenia. Neuropsychol Rev. 2009 Sep;19(3):353-64. doi: 10.1007/s11065-009-9097-y. Epub 2009 May 15. Review. — View Citation

Medalia A, Richardson R. What predicts a good response to cognitive remediation interventions? Schizophr Bull. 2005 Oct;31(4):942-53. Epub 2005 Aug 24. — View Citation

Medalia A, Saperstein A. The role of motivation for treatment success. Schizophr Bull. 2011 Sep;37 Suppl 2:S122-8. doi: 10.1093/schbul/sbr063. Review. — View Citation

Montag C, Dziobek I, Richter IS, Neuhaus K, Lehmann A, Sylla R, Heekeren HR, Heinz A, Gallinat J. Different aspects of theory of mind in paranoid schizophrenia: evidence from a video-based assessment. Psychiatry Res. 2011 Apr 30;186(2-3):203-9. doi: 10.1016/j.psychres.2010.09.006. Epub 2010 Oct 14. — View Citation

Nakagami E, Hoe M, Brekke JS. The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia. Schizophr Bull. 2010 Sep;36(5):935-48. doi: 10.1093/schbul/sbq043. Epub 2010 May 12. — View Citation

Nasrallah H, Morosini P, Gagnon DD. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia. Psychiatry Res. 2008 Nov 30;161(2):213-24. doi: 10.1016/j.psychres.2007.11.012. Epub 2008 Oct 11. — View Citation

Penn D, Roberts DL, Munt ED, Silverstein E, Jones N, Sheitman B. A pilot study of social cognition and interaction training (SCIT) for schizophrenia. Schizophr Res. 2005 Dec 15;80(2-3):357-9. Epub 2005 Aug 31. — View Citation

Penn DL, Corrigan PW, Bentall RP, Racenstein JM, Newman L. Social cognition in schizophrenia. Psychol Bull. 1997 Jan;121(1):114-32. Review. — View Citation

Penn DL, Sanna LJ, Roberts DL. Social cognition in schizophrenia: an overview. Schizophr Bull. 2008 May;34(3):408-11. doi: 10.1093/schbul/sbn014. Epub 2008 Mar 28. — View Citation

Penn DL, Spaulding W, Reed D, Sullivan M. The relationship of social cognition to ward behavior in chronic schizophrenia. Schizophr Res. 1996 Jul 5;20(3):327-35. — View Citation

Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003 Nov 1;121(1):31-49. — View Citation

* Note: There are 63 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Movie to Assess Social Cognition (MASC) Changes in the aggregates (average) of standardized performance levels : z-scores of Theory of Mind (range 0-45) during social cognitive remediation Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Positive and Negative Symptoms Scale for Schizophrenia (PANSS) Changes in the aggregates (average) of standardized performance levels : z-scores of positive and negative symptoms (minimum score 30- maximum score 210) of schizophrenia after social cognitive remediation Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Personal and Social Performance scale (PSP) Changes in the aggregates (average) of standardized performance levels : z-scores of social function (0 to 100) after social cognitive remediation Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Self Esteem Rating Scale (SERS) Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 10-maximum score 70) in self-assessment of self-esteem Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Boston University Empowerment Scale (BUES) Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 1- maximum score 4) in self-assessment of empowerment Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Internalized Stigma of Mental Illness (ISMI) self-assessment of internalized stigma Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Stages of Recovery Instrument (STORI) Self-assessment of personal recovery Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Social Perception and Knowledge (PerSo) cognitive task to assess competence in perception of social situations and social knowledge Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Ambiguous Intentions and Hostility Questionnaire (AIHQ) Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 1, maximum score 6) at a cognitive task to measure hostile social cognitive bias Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Questionnaire of Cognitive and Affective Empathy Changes in the aggregates (average) of standardized performance levels : z-scores (minimum score 31, maximum score 124) in a self-assessment of empathy Changes between baseline function, after intervention and at 6 months of follow-up
Secondary French National Adult Reading Test (f-NART cognitive task to assess premorbid intellectual quotient (IQ) Baseline measure only
Secondary Trail Making Test A (TMT A) cognitive task to assess speed of processing Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Trail Making Test B (TMT B) cognitive task to assess reactive mental flexibility Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Self-assessment of Social Cognition (AcSo) self-assessment of patient' perception of social cognitive deficits Changes between baseline function, after intervention and at 6 months of follow-up
Secondary Commission Test (modified zoo test) cognitive task to asess planification abilities Changes between baseline function, after intervention and at 6 months of follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A